News Nov 18, 2024 Alimentiv Partners on a New Alcoholic Hepatitis Phase 1b Clinical Trial September 2024 – Alimentiv is proud to partner on an exciting new Phase 1b clinical trial in severe alcohol-associated hepatitis, an area with high mortality… Read Now
Publication Nov 6, 2024 Efficacy and Safety of Advanced Combination Treatment in Immune-Mediated Inflammatory Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Christopher Ma, Vipul Jairath, Virginia Salitano Read Now
Publication Feb 1, 2022 Responsiveness of a Histologic Scoring System Compared With Peak Eosinophil Count in Eosinophilic Esophagitis Arjan Bredenoord, Brian Feagan, Christopher Ma, Evan Dellon, Guangyong Zou, Lisa M Shackelton, Stefanie C McFarlane, Vipul Jairath Read Now
Publication Jan 25, 2022 Underrepresentation of Minorities and Lack of Race Reporting in Ulcerative Colitis Drug Development Clinical Trials Christopher Ma, Malcolm Hogan, Rocio Sedano, Vipul Jairath Read Now
Publication Jan 18, 2022 Janus Kinase Inhibitors for the Management of Patients With Inflammatory Bowel Disease Brian Feagan, Christopher Ma, Rocio Sedano, Vipul Jairath Read Now
Publication Jan 16, 2022 Design of Clinical Trials for Mild to Moderate Ulcerative Colitis Rocio Sedano, Vipul Jairath Read Now
Publication Jan 3, 2022 A Clinical Prediction Model to Determine Probability of Response to Certolizumab Pegol for Crohn’s Disease Brian Feagan, Niels Vande Casteele, Vipul Jairath Read Now
Publication Dec 24, 2021 A Clinical Prediction Model to Determine Probability of Response to Certolizumab Pegol for Crohn’s Disease Brian Feagan, Lisa M Shackelton, Niels Vande Casteele, Vipul Jairath Read Now
